Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
-
13681
-
13682
-
13683
-
13684
-
13685
-
13686
-
13687
-
13688
-
13689
Table 1_Gamma knife radiosurgery for cerebral cavernous malformations: biologically effective dose predicts therapeutic outcomes.docx
Published 2025“…Fowler, has been widely discussed in radiobiology but not evaluated in CCMs.</p>Methods<p>A retrospective cohort study was conducted on 107 patients with 123 CCMs treated by GKRS at West China Hospital between June 2020 and December 2022. …”
-
13690
-
13691
-
13692
-
13693
-
13694
-
13695
-
13696
-
13697
-
13698
Dietary supplements use by patients with CIBD.
Published 2024“…<div><p>Background/Aims</p><p>Chronic inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis are known for a combination of food intolerance, decreased oral intake, and malabsorption which all predispose patients to malnutrition and suboptimal dietary intake. …”
-
13699
Socioeconomic characteristics of the sample.
Published 2024“…<div><p>Background/Aims</p><p>Chronic inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis are known for a combination of food intolerance, decreased oral intake, and malabsorption which all predispose patients to malnutrition and suboptimal dietary intake. …”
-
13700
S1 Data set -
Published 2023“…Patients with government employment (AOR = 0.48; 95% CI 0.26, 0.90), antiplatelet drug use (AOR = 0.29; 95% CI 0.16, 0.52), and medication for treating dyslipidemia (AOR = 0.54; 95% CI 0.35, 0.84), all had a decreased chance of developing a chronic diabetes problem.…”